Psychemedics Corporation

Psychemedics (NASDAQ: PMD) develops and delivers the world’s leading hair drug test for detecting drugs of abuse. Some of the most well-known companies in the Fortune 500, largest police departments and schools across the country use Psychemedics’ patented drug tests using hair to ensure safer workplaces and campuses. After 30 years, the company remains the drug testing industry’s leading innovator and consistently advances the science of hair testing for drugs of abuse.

Employing the leading scientists in the field of drug detection science, Psychemedics protects businesses by identifying more drug users for more companies than any other hair testing laboratory in the world. Unique among laboratories, all Psychemedics drug screens are FDA 510k approved. Those tests include the 5 panel drug test and additional tests for emerging threats like fentanyl and benzodiazepines.